MaxVal announces support for USPTO’s authentication changes

MaxVal announces that all of our software products and services now support the USPTO’s upcoming Private PAIR changes. The USPTO recently announced that as of February 15, 2019, EFS-Web and Private PAIR users will have a safer and simpler way to login.  They are moving from using PKI certificates to a new two-factor authentication method, which will use USPTO.gov accounts. Logging in with a USPTO.gov account will help users eliminate shared credentials; modernize security processes; save time by granting access to multiple USPTO systems with one consolidated sign-in process; ensure USPTO compliance with the latest Federal Information Security Management Act

Continue reading

Hot Topics in Tech | December 2018 Newsletter

In the December issue of the “Hot Topics in Tech” newsletter series, we take a glance at how mobile devices have transformed healthcare and became a crucial component in the medical field. Also, we illustrate the various types of mobile health applications (mHealth) by way of examples and examine the FDA clearance pattern for these mHealth applications along with their market forecast.

Continue reading

MaxVal Publishes Advanced Landscape Report on E-Cigarettes

MaxVal’s E-Cigarettes report is now available through Patent LiveScape™, an analysis and reporting service that provides clients with interactive reports which extract actionable and predictive information. By leveraging data sciences best practices, MaxVal has constructed an interactive report that melds different yet related data sources into a comprehensive landscape, allowing the reader to dynamically explore relationships. What sets MaxVal apart, aside from its novel report delivery methods, are its experienced professionals with expertise that spans multiple domains. The MaxVal team is accustomed to working with complicated data from disparate sources and generating outputs that are pleasing to clients. Learn about

Continue reading

Hot Topics in Tech | November 2018 Newsletter

In this issue of the “Hot Topics in Tech” series, we provide a brief overview of the patent filing activity around implantable non-energy based devices for hypertension treatment and management. We have also presented the top technologies within this domain, leading assignees, and market information. With regard to Artificial Intelligence, we have highlighted various types of chat bots based on the use of AI and illustrated the filing trend and leading players in this domain. In addition, we have presented the top cited patents in the technology and some market predictions related to chat bots.

Continue reading

What to Know About the USPTO Access to Relevant Prior Art Initiative

The USPTO recently announced its Relevant Prior Art (RPA) Initiative, seeking to leverage electronic resources to improve an examiner’s access to relevant information from applicant’s other related applications.  These resources may include related U.S. applications, international applications under the PCT, and counterpart foreign applications by the same applicant. What are the advantages? Simplifies application process for applicant Speeds up examination process Increases efficiency of prosecution procedures Improves prosecution quality What you should be aware of Notification of application included in RPA initiative.  You will receive a Notice of Imported Citations informing you of your application’s inclusion in the Initiative and

Continue reading

MaxVal Publishes Advanced CRISPR-Cas9 Report

Following the publication of our recent Technology Landscape study on CRISPR-Cas9, MaxVal announces the latest advanced publication on the genome editing system, CRISPR, which has become an extremely important tool in medical research.  The demonstration of the reprogrammable nature of Cas9 served as a catalyst to widespread adoption of CRISPR systems in biomedical and agricultural research.  The potential benefits of CRISPR gene editing in several challenging diseases such as Alzheimer’s, cancer, and numerous autoimmune diseases are being explored by researchers. MaxVal’s CRISPR report is now available through Patent LiveScape™, an analysis and reporting service that provides clients with interactive reports which extract

Continue reading